Weight loss drug windfall attracts pharma companies
Source: Reuters SAN FRANCISCO, Jan 11 (Reuters) – Pharmaceutical executives from Amgen (AMGN.O) to Pfizer (PFE.N) are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk’s (NOVOb.CO) Wegovy and Zepbound from Eli Lilly (LLY.N). At stake is a market that is now estimated to reach $100 billion at […]
Generative AI in the pharmaceutical industry: Moving from hype to reality
Source: mckinsey.com The technology could offer pharma companies a once-in-a-century opportunity – but only if they learn to scale it and address the industry’s unique challenges. Accelerated drug discovery. More efficient clinical trials. Quicker regulatory approvals. Ultra targeted marketing and medical materials generated in-house. Generative AI is transforming nearly all aspects of the pharmaceutical industry, revamping […]
Mumbai Police raids drug producing lab, arrests 2 with mephedrone worth crores
Source: India Today The Mumbai Police on Thursday arrested two people for allegedly operating a lab for illegally manufacturing a synthetic drug named mephedrone. The police also seized mephedrone having a market value of Rs 1.065 crore and other chemicals and machines worth Rs five lakh. The two men arrested were identified as Abrar Shaikh […]
Pharmacovigilance Industry Survey Report 2023: Trends on Transformation
Written: Abid Ali Khan The findings from the Pharmacovigilance Industry Survey Report for 2023 provide valuable insights into the current landscape of pharmacovigilance practices and the future direction of the industry. Here’s a breakdown of the key findings: Compliance, Quality, and Operational Efficiency: The primary focus areas for pharmacovigilance teams are compliance with regulations, ensuring […]
Overhaul in pharma manufacturing: India imposes stringent quality controls.
Source: Business Line Concerns raised by health authorities and non-compliance with international standards have prompted this push, with large companies given a six-month deadline and smaller ones a 12-month timeframe to comply. India has tightened rules to ensure mandatory compliance with good manufacturing practices – which looks at bringing in quality control on materials, machines, […]
Implementing revised Schedule M rules uphill task for small pharma
Source: Business Standard A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The […]
What Is Aspartame? Here Is All That You Need To Know About It
Source: News18 The term ‘aspartame’ has taken over the internet recently and how. It has been discovered that this element which is rather injurious to human health is actually present in a lot of our favourite food and beverage element. While everybody has a lot of opinions about it, very few know in detail about […]
NPPA fixes rates of 19 formulations
Source: Zeebiz The National Pharmaceutical Pricing Authority (NPPA), under the government’s Department of Pharmaceuticals, fixed the retail prices of 19 drugs with effect from January 1, 2024. The new rates of the drugs, including those used to treat fever, pain and infections, exclude goods and services tax (GST), according to an official notification. Serial No. […]
CBI to undertake investigation of Delhi Fake Medicine Scam
Source: Business Standard The Central Bureau of Investigation (CBI) will inquire into the supply of substandard medicines in three government hospitals run by the Government of National Capital Territory of Delhi. The inquiry was ordered by the Ministry of Home Affairs on Friday, following a recommendation by Delhi Lieutenant Governor V K Saxena in December […]
The story of a drug that India has failed to ban
Source: Scroll The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies. In 2009, an article in Monthly Index of Medical Specialities drew attention to a psychiatric drug from Denmark being sold in the Indian market. In the article, the […]